Hepatic Cell News Volume 5.06 | Feb 19 2021

    0
    30






    2021-02-19 | HCN 5.06


    Hepatic Cell News by STEMCELL Technologies
    Vol. 5.06 – 19 February, 2021
    TOP STORY

    6His‐Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species

    In cultured hepatic stellate cells, extracellular 6His‐tagged recombinant human cytoglobin was endocytosed and accumulated in endosomes via clathrin‐mediated pathway.
    [Hepatology]

    Abstract

    In this webinar on hepatic organoids review the biological characteristics and practical considerations of adding organoids to your research.
    PUBLICATIONSRanked by the impact factor of the journal

    Cordycepin Ameliorates Nonalcoholic Steatohepatitis via Activation of AMP‐Activated Protein Kinase Signaling Pathway

    Researchers evaluated the effects of cordycepin on lipid storage in hepatocytes, inflammation, and fibrosis development in mice with nonalcoholic steatohepatitis.
    [Hepatology]

    Abstract

    HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness

    Scientists report that HDAC11 was highly expressed in hepatocellular carcinoma and was closely related to disease prognosis. Depletion of HDAC11 in a conditional knockout mouse model reduced hepatocellular tumorigenesis and prolonged survival.
    [Cancer Research]

    Abstract

    A Hexokinase Isoenzyme Switch in Human Liver Cancer Cells Promotes Lipogenesis and Enhances Innate Immunity

    Researchers showed that in hepatocellular carcinoma tumors the highest expression level of HK2 was inversely correlated to GCK expression, and was associated to poor prognosis for patient survival.
    [Communications Biology]

    Full Article

    Lactonic Sophorolipid–Induced Apoptosis in Human HepG2 Cells through the Caspase-3 Pathway

    The effects of lactonic sophorolipids and cell death inhibitors were measured by MTT test on HepG2 cells. Their morphology of the cells was observed under a microscope.
    [Applied Microbiology and Biotechnology]

    AbstractGraphical Abstract

    Overexpression of Ring Finger Protein 20 Inhibits the Progression of Liver Fibrosis via Mediation of Histone H2B Lysine 120 Ubiquitination

    To mimic liver fibrosis in vitro, LX-2 cells were treated with TGF-β. Gene and protein expressions were detected by RT-qPCR and western blot, respectively.
    [Human Cell]

    Abstract

    C2orf40 Inhibits Hepatocellular Carcinoma through UBR5-Dependent or p53-Independent Mechanisms

    The recovery of C2orf40 expression in hepatocellular carcinoma cell lines could induce G0/G1 phase arrest and apoptosis, and also inhibit cell migration and invasion by reversing the epithelial–mesenchymal transition process, both in vivo and in vitro.
    [Journal of Gastroenterology and Hepatology]

    Abstract
    Survey Report: Where Is Pluripotent Stem Cell Research Now?
    REVIEWS

    Stress Kinases in the Development of Liver Steatosis and Hepatocellular Carcinoma

    The authors summarize findings indicating that the dysregulation of stress kinases plays a fundamental role in the development of steatosis and are important players inducing liver fibrosis.
    [Molecular Metabolism]

    Abstract

    Antiplatelet Drugs and Liver Fibrosis

    Investigators discuss the role of platelets in liver fibrosis and accompanying hemostatic disorders. They present the results of animal and human studies on antiplatelet drugs in liver disorders and their potential therapeutic utility.
    [Platelets]

    Abstract
    INDUSTRY AND POLICY NEWS

    Ferris State University Pharmacy Associate Professor Awarded $377,805 Anticancer Drug Research Grant

    Associate Professor of Medicinal Chemistry at Ferris State University, Dr. Sonali Kurup has learned the National Institutes of Health approved her proposal for $377,805 to fund an investigation into novel dual-targeted inhibitors of EGFR and aurora kinase. These enzymes contribute to uncontrolled cancer cell division and resistance to approved anticancer agents.
    [Ferris State University]

    Press Release
    FEATURED EVENT

    EMBO Workshop: Long-Distance Cell-Cell Signaling in Development and Disease

    September 5 – 8, 2021
    Exeter, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Director – Solid Tumors

    Gilead Sciences, Inc. – Foster City, California, United States

    Postdoctoral Fellow – p53 and Metabolism

    The Francis Crick Institute – London, England, United Kingdom

    Postdoctoral Associate – NAFLD and Hepatocellular Carcinoma

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Fellow – Immunogenetics and Tumor Immunology

    The University of Texas Southwestern Medical Center – Dallas, Texas, United States

    Senior Researcher – Translational Cell Assays

    Karolinska Institutet – Stockholm, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter